Literature DB >> 10228900

CA 125--epitopes and molecular size.

K Nustad1, M Onsrud, B Jansson, D Warren.   

Abstract

CA 125 has two main immunogenic areas reactive with mouse and rat monoclonal antibodies. These areas are defined by the antibodies OC 125 and M11, respectively. Antibodies related to the main groups are named OC 125-like and M 11-like antibodies. The OC 125-like antibodies can be subgrouped into four sets, whereas the M 11-like antibodies segregate into many closely related binding specificities. One M 11-like antibody, ZR38, is not fully inhibited by any other M 11-like antibody and therefore represents a distinct subgroup. A single antibody, OV 197, is related to some OC 125-like antibodies, but not to OC 125. However, OC 125 enhances binding of OV 197 to its epitope. A new antibody, 7C 12, induces conformation changes, affecting binding of some M 11-like and some OC 125-like antibodies. CA 125 exists as very large molecules that can be partly disrupted by SDS and heat. The form found in serum might be a degradation product from a larger molecule found in the abdominal and other serous cavities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10228900     DOI: 10.1177/172460089801300404

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   3.248


  3 in total

1.  CA125 in ovarian cancer.

Authors:  Nathalie Scholler; Nicole Urban
Journal:  Biomark Med       Date:  2007-12       Impact factor: 2.851

2.  Biochemical and morphological differences between CA125 isolated from healthy women and patients with epithelial ovarian cancer from Tunisian population.

Authors:  Houda Bouanène; Walid Saibi; Moncef Mokni; Badreddine Sriha; L Ben Fatma; H Ben Limem; S Ben Ahmed; Ali Gargouri; Abdelhédi Miled
Journal:  Pathol Oncol Res       Date:  2011-09-07       Impact factor: 3.201

3.  Polymeric micelle-based bioassay with femtomolar sensitivity.

Authors:  Fouzi Mouffouk; Yasmin Chishti; Qiaoling Jin; Michelle E Rosa; Melixa Rivera; Siva Dasa; Liaohai Chen
Journal:  Anal Biochem       Date:  2007-10-22       Impact factor: 3.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.